Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07197515 · ClinicalTrials.gov registry record · NA

Legal Evaluation for Greater Access to Cancer Care (LEGAL-CARE)

A NA study of Cancer, sponsored by University of Alabama at Birmingham.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT07197515: Recruiting NA study of Cancer, sponsored by University of Alabama at Birmingham.

NCT07197515 is a NA study of Cancer that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 50 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07197515, a NA study of Cancer, is actively recruiting participants, sponsored by University of Alabama at Birmingham.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

This study aims to help patients with cancer facing legal issues. The investigators noticed that many patients struggle with laws and regulations related to disability benefits, employment rules, health insurance denials, and financial assistance barriers among many others. To understand this better, the investigators conducted the first nationwide study on how legal problems affect patients with cancer. Investigators noted a striking prevalence of legal issues in patients with cancer - most struggled with 2 or more legal issues that impacted their care. These legal issues looked different for those with different socioeconomic backgrounds. In a second study, the investigators also found healthcare workers (HCWs) including social workers and navigators feel underprepared to counsel patients on legal topics. Now, the investigators launching a pilot program called LEGAL-CARE at the O'Neal Comprehensive Cancer Center at the University of Alabama at Birmingham (UAB) to help patients navigate these legal hurdles. Patients in the study will receive legal navigation, where they will get help with legal issues related to their cancer treatment. The investigators will look at how practical or feasible such a program is, and how it affects patients' lives over time. The investigators will check in with the participants at regular time intervals to see if they feel less stressed about money, have a better quality of life, and use healthcare services differently. The investigators will also see if the program helps reduce the number of legal problems they face. Finally, the investigators will discuss with the participants about how this legal intervention could be made better. This study is important because it's the first of its kind. It will give insights into how legal problems impact patients with cancer and how addressing these issues can improve their lives. Plus, it'll help the investigators better understand implementing similar programs in other places. Overall, it'

Primary Outcome

Feasibility will be measured by 1. retention of ≥70% of enrolled patients at 6 months and 2. ≥75% completion of biweekly surveys among retained patients. Acceptability will be measured by the Acceptability of Intervention Measure (AIM), 4 items on a 5-point Likert scale (1-5; higher = more acceptable). Appropriateness will be measured by the Intervention Appropriateness Measure (IAM), 4 items on a 5-point Likert scale (1-5; higher = more appropriate). Feasibility (perceptions) will be measur

Conditions Studied

Interventions

  • BEHAVIORAL Legal Navigation

Study Locations (1)

Alabama

  • The Kirklin Clinic - Birmingham

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2025-10-01
Est. Completion 2027-01-31
Phase NA
University of Alabama at Birmingham

1,160 total trials

What NCT07197515 shows while recruiting

NCT07197515 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which Legal Navigation is the first listed.

NCT07197515 reports a single indexed study location in Alabama.

Frequently Asked Questions

What is clinical trial NCT07197515 about?

NCT07197515 is a clinical study titled "Legal Evaluation for Greater Access to Cancer Care (LEGAL-CARE)". This study aims to help patients with cancer facing legal issues. The investigators noticed that many patients struggle with laws and regulations related to disability benefits, employment rules, health insurance denials, and financial assistance barriers among many others. To understand this better...

What is the current status of trial NCT07197515?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2025-10-01. Estimated completion is 2027-01-31.

What conditions does trial NCT07197515 study?

This clinical trial studies the following conditions: Cancer.

What interventions are being tested in trial NCT07197515?

The interventions under investigation include: Legal Navigation (BEHAVIORAL).

Who is sponsoring clinical trial NCT07197515?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07197515 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07197515's enrollment target sits among peer trials

50 422nd of 615 higher than 179 of 615 other Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07197515, the US trial registry maintained by the National Library of Medicine. NCT07197515 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.